enGene Therapeutics Inc. (ENGN)
Market Closed
1 Sep, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
1. 85
+0.01
+0.8152%
$
123.26M Market Cap
- P/E Ratio
- Div Yield
1.29M Volume
- Eps
$ 1.84
Previous Close Investors:
Want to track ENGN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
enGene Therapeutics Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Point72 Asset Management LP Point72 Asset Management LP | 13,992 | $24,206 | $23,786.4 | -$419.6 | -1.73% |
 Ilko Menkov Vestal Point Capita LLP | 1.67M | $2.88M | $2.83M | -$50,023.07 | -1.73% |
 Christopher C. Powers Farther Finance Advisors, LLC | 100 | $173 | $179 | $6 | 3.47% |
 David Vollmer PFS Partners, LLC | 11,000 | $19,030 | $19,690 | $660 | 3.47% |
 Raymond Debbane Siren, L.L.C. | 6.26M | $10.82M | $10.64M | -$187,699.86 | -1.73% |
| NCG Noah C Goldberg Jain Global LLC | 43,231 | $74,790 | $73,492.7 | -$1,297.3 | -1.73% |
| PLC Peapod Lane Capital LLC Peapod Lane Capital LLC | 1.1M | $1.91M | $1.97M | $66,128.72 | 3.47% |
| AH Anders Hove Acorn Capital Advisors LLC | 1.27M | $2.2M | $2.16M | -$38,138.09 | -1.73% |
 Yuen Man Lee Persistent Asset Partners Ltd. | 114,493 | $198,073 | $206,087.4 | $8,014.4 | 4.05% |
